The real inflection point in biotech CEO compensation isn’t between early and late clinical trials. It’s the leap from pre-clinical ...
Using data from the Thelander AI in VC report (available on the Thelander Platform for no charge), we looked at ...
Any day Thelander data is used in a Halle Tecco, MPH, MBA blog post is a good day. Halle updated ...
In honor of America’s 250th birthday, we’re sharing real-time comp data (straight from the Thelander platform) for all investment firms ...
Dedicated in-house marketing teams at investment firms is still relatively rare, but that’s changing. Firms like Lightspeed are leading the shift, with ...
Fundraising rounds at private companies are getting larger at every stage. In this month’s digest, we are digging into the ...
As venture rounds get bigger and the sub-$5M round disappears (PitchBook), it’s changed the way that companies recruit and retain ...
One time is random. Twice is a pattern. I got off the phone with a biotech VC today who was ...
Venture capital firms are increasingly building out dedicated talent teams to help portfolio companies hire executives and scale their teams, ...
Global M&A hit a historic milestone in Q1 2026. According to PitchBook, “total deal value reaching an estimated $1.6 trillion—a ...